Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial : The Lancet Neurology
Links shared publicly online about this topic.
- 876total visits
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial : The Lancet Neurology
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. By - Prof Yukito Shinohara MD, Prof Yasuo Katayama MD, Prof Shinichiro...
View full resource at thelancet.com
Tags: Neurology, Stroke, Thrombotic Event
Most Recently Shared on September 13, 2010 at 1:22 pm By:
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non ...: T... http://bit.ly/c8G23N
Advertisement
